# In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy

> **NCT01976780** · PHASE4 · COMPLETED · sponsor: **Global Emerging Infections Surveillance and Response System** · enrollment: 118 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate
- **DRUG:** Artemether Lumefantrine
- **DRUG:** Mefloquine

## Key facts

- **NCT ID:** NCT01976780
- **Lead sponsor:** Global Emerging Infections Surveillance and Response System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2017-05-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01976780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01976780, "In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01976780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*